Chimeric Therapeutics is trading at A$0.01, +16.67% now after recent heavy selling.
- The September 4 application to quote 14,814,814 new shares may have increased supply, but no source directly links it to the September 8 movement.
- No verified company-specific announcement or broader-market move clearly explains the gain; confidence remains low.